Waters new Rapid Screening-DSC enables up to 24x faster thermal stability testing at ultra-low sample volumes for antibody drugs

FHS
July 24, 2024
11:36 am

Waters Corporation announced today the global release of the TA Instruments™ Rapid Screening-Differential Scanning Calorimeter (TA Instruments RS-DSC), designed for biopharmaceutical developers. The TA Instruments RS-DSC is a high-throughput DSC for precise thermal stability testing of high-concentration biologic formulations specifically for antibody drugs and engineered proteins

AdvaMed says CMS radiotherapy rate cut proposal will limit patient access

Dive Brief: AdvaMed has accused the Centers for Medicare and Medicaid Services (CMS) of proposing “drastic cuts” to radiotherapy reimbursement. The agency’s proposed physician fee

July 17, 2023

Candel wins FDA orphan drug designation for pancreatic cancer drug – Pharmaceutical Technology

Share this article Though a range of therapies are available for pancreatic cancer, survival rate remains low. Image credit: Shutterstock/AlexLMX. The US Food and Drug

April 12, 2024

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

There are a lot of reasons why updated data on Pfizer’s Lorbrena, a treatment for non-small cell lung cancer, might not seem to be a

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.